Skip to main content
Log in

Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose

To retrospectively determine whether enhancement patterns in the pancreatic and equilibrium phases of computed tomography (CT) for pancreatic neuroendocrine neoplasms are related to prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens.

Methods

Twenty-five pancreatic neuroendocrine neoplasms in 22 patients underwent preoperative dynamic CT. Tumors were classified into two groups by enhancement patterns on preoperative CT. A washout pattern was defined as peak enhancement in the pancreatic phase with washout of at least 60 Hounsfield units in the equilibrium phase. Group 1 comprised tumors showing a washout pattern in more than half of tumor and Group 2 comprised tumors showing a washout pattern in less than half of the tumor. The Ki-67 index and the presence of vascular invasion were evaluated in surgical specimens. The Ki-67 index from biopsy specimens was compared with that from surgical specimens.

Results

There were 12 surgical specimens in Group 1 and 13 in Group 2. Group 2 showed significant correlations with larger Ki-67 indices (p < 0.05) and positive vascular invasion (p < 0.05). The Ki-67 index discrepancy between biopsy and surgical specimens of Group 2 was significantly greater than that of Group 1 (p < 0.05).

Conclusions

Pancreatic neuroendocrine neoplasms in which less than half of the tumor showed a washout pattern were correlated with poor prognostic factors. Analysis of enhancement patterns may provide predictive information about whether endoscopic ultrasound-guided fine-needle aspiration biopsy is reliable for the assessment of Ki-67 index.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Klimstra DS, Capella C, Arnold R (2010) Neuroendocrine neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al. (eds) WHO Classification of Tumours of the Digestive System, 4th edn. Lyon, France: IARC Press, pp 322–326

    Google Scholar 

  2. Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al. (2004) Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 28:1145–1153

    Article  PubMed  Google Scholar 

  3. Schmitt AM, Anlauf M, Rousson V, et al. (2007) WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 31:1677–1682

    Article  PubMed  Google Scholar 

  4. Horton KM, Hruban RH, Yeo C, Fishman EK (2006) Multi-detector row CT of pancreatic islet cell tumors. Radiographics 26:453–464

    Article  PubMed  Google Scholar 

  5. Rha SE, Jung SE, Lee KH, et al. (2007) CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 62:371–377

    Article  PubMed  Google Scholar 

  6. Lewis RB, Lattin GE Jr, Paal E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30:1445–1464

    Article  PubMed  Google Scholar 

  7. Hayashi D, Tkacz JN, Hammond S, et al. (2011) Gastroenteropancreatic neuroendocrine tumors: multimodality imaging features with pathological correlation. Jpn J Radiol 29:85–91

    Article  PubMed  Google Scholar 

  8. Ichikawa T, Peterson MS, Federle MP, et al. (2000) Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 216:163–171

    PubMed  CAS  Google Scholar 

  9. Rodallec M, Vilgrain V, Couvelard A, et al. (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6:77–85

    Article  PubMed  CAS  Google Scholar 

  10. d’Assignies G, Couvelard A, Bahrami S, et al. (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416

    Article  PubMed  Google Scholar 

  11. Hattori Y, Gabata T, Matsui O, et al. (2009) Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol 15:3114–3121

    Article  PubMed  Google Scholar 

  12. La Rosa S, Klersy C, Uccella S, et al. (2009) Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 40:30–40

    Article  PubMed  Google Scholar 

  13. Rindi G, Klöppel G, Couvelard A, et al. (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757–762

    Article  PubMed  CAS  Google Scholar 

  14. Herwick S, Miller FH, Keppke AL (2006) MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol 187:W472–W480

    Article  PubMed  Google Scholar 

  15. Micke P, Ostman A (2005) Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets 9:1217–1233

    Article  PubMed  CAS  Google Scholar 

  16. Hwang RF, Moore T, Arumugam T, et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68:918–926

    Article  PubMed  CAS  Google Scholar 

  17. Aranha GV, Georgen R (1989) Gastric linitis plastica is not a surgical disease. Surgery 106:758–762

    PubMed  CAS  Google Scholar 

  18. Amorn Y, Knight WA Jr (1978) Primary linitis plastica of the colon: report of two cases and review of the literature. Cancer 41:2420–2425

    Article  PubMed  CAS  Google Scholar 

  19. Dawson PJ, Karrison T, Ferguson DJ (1986) Histologic features associated with long-term survival in breast cancer. Hum Pathol 17:1015–1021

    Article  PubMed  CAS  Google Scholar 

  20. Asayama Y, Yoshimitsu K, Irie H, et al. (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150–155

    Article  PubMed  Google Scholar 

  21. Marion-Audibert AM, Barel C, Gouysse G, et al. (2003) Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 125:1094–1104

    Article  PubMed  Google Scholar 

  22. Couvelard A, O’Toole D, Turley H, et al. (2005) Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 92:94–101

    Article  PubMed  CAS  Google Scholar 

  23. Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. (2007) Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 13:187–196

    Article  PubMed  CAS  Google Scholar 

  24. Ekeblad S, Skogseid B, Dunder K, et al. (2008) Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 14:7798–7803

    Article  PubMed  CAS  Google Scholar 

  25. Pape UF, Jann H, Müller-Nordhorn J, et al. (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265

    Article  PubMed  Google Scholar 

  26. Strosberg J, Nasir A, Coppola D, Wick M, Kvols L (2009) Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Hum Pathol 40:1262–1268

    Article  PubMed  Google Scholar 

  27. Yang Z, Tang LH, Klimstra DS (2011) Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol 35:853–860

    Article  PubMed  Google Scholar 

  28. Figueiredo FA, Giovannini M, Monges G, et al. (2009) EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endoscopy 70:907–914

    Article  Google Scholar 

Download references

Acknowledgment

We thank Mami Gyouba and Yuka Mori for their contributions in the preparation of pathologic data.

Conflicts of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihisa Kodama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tatsumoto, S., Kodama, Y., Sakurai, Y. et al. Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens. Abdom Imaging 38, 358–366 (2013). https://doi.org/10.1007/s00261-012-9953-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-012-9953-8

Keywords

Navigation